Table 2.
Pharmacological action | Clinical effect |
Calcium channel inhibitor | Anti-atherogenic effect |
Beta receptor agonist | Improvement of urinary disturbance |
Protein kinase C inhibitor | Improvement of coldness in legs |
Anticoagulant and antithrombogenic activities | Improvement of numbness in legs |
Superoxide dismutase mimicking activity | |
Lipid metabolism regulation | |
Glycometabolism regulation | |
Diuretic activity | |
Improvement of kidney function |